The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMW 2019 | AL amyloidosis treatment options
Vaishali Sanchorawala, MD, Boston University School of Medicine, Boston, MA, discusses different options for AL amyloidosis treatments, depending on eligibility for STEM cell transplant, and the subsequent success of these treatments. Interview recorded at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.
